Product
AD-218A
1 clinical trial
1 indication
Indication
DyslipidemiaClinical trial
A Randomized, Double-blinded, Active-controlled, Multicenter Phase 3 Clinical Trial and Open-label, Extension Study to Evaluate the Efficacy and Safety of AD-218 in Patients With Mixed DyslipidemiaStatus: Recruiting, Estimated PCD: 2025-03-31